The Latin America, Middle East and Africa Biopsy Devices Market should witness market growth of 12.7% CAGR during the forecast period (2022-2028).
Biopsies can be executed in the erect or decubitus location with these add-on structures. Thus, patients who surpass the weight limit of the table for the prone biopsy device are appropriate applicants for tomosynthesis-guided biopsies.
Also, the patients with comorbidities (like respiratory issues, arthritic conditions, prior surgery, or limited mobility) that can stop them from lying on the radiosurgery table vulnerable for a long time are appropriate applicants for these biopsies.
Locating is much easy with the erect device as there is no disturbance from the biopsy table. In addition, posterior lesions are much effortlessly biopsied as the erect perspective allows better entrance to the posterior tissues.
Compared to other Middle East countries, Egypt has a large healthcare sector. As the government of Egypt is intensely interested in growing the healthcare sector, Egypt bids a lot of prospects in developing medical services. In the past year, Egypt has raised public investment by 205%, allowing for the bolstering of the healthcare system during the pandemic.
The Brazil market dominated the LAMEA Biopsy Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $53.1 million by 2028.The Argentina market is experiencing a CAGR of 13.3% during (2022-2028). Additionally, The UAE market would display a CAGR of 12.4% during (2022-2028).
Based on Product, the market is segmented into Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps and Others. Based on Needle-based Biopsy Guns Type, the market is segmented into Vacuum-assisted Biopsy (VAB) Devices, Fine Needle Aspiration Biopsy (FNAB) Devices and Core Needle Biopsy (CNB) Devices. Based on Biopsy Guidance Systems Type, the market is segmented into Manual and Robotic. Based on Biopsy Needles Type, the market is segmented into Disposable and Reusable. Based on End-user, the market is segmented into Hospitals, Diagnostic & Imaging Center and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Hologic, Inc., Fujifilm Holdings Corporation, B. Braun Melsungen AG, Danaher Corporation, ConMed Corporation, Becton, Dickinson and Company, Cardinal Health, Inc., Argon Medical Devices, Inc., and Cook Medical, Inc.
Biopsies can be executed in the erect or decubitus location with these add-on structures. Thus, patients who surpass the weight limit of the table for the prone biopsy device are appropriate applicants for tomosynthesis-guided biopsies.
Also, the patients with comorbidities (like respiratory issues, arthritic conditions, prior surgery, or limited mobility) that can stop them from lying on the radiosurgery table vulnerable for a long time are appropriate applicants for these biopsies.
Locating is much easy with the erect device as there is no disturbance from the biopsy table. In addition, posterior lesions are much effortlessly biopsied as the erect perspective allows better entrance to the posterior tissues.
Compared to other Middle East countries, Egypt has a large healthcare sector. As the government of Egypt is intensely interested in growing the healthcare sector, Egypt bids a lot of prospects in developing medical services. In the past year, Egypt has raised public investment by 205%, allowing for the bolstering of the healthcare system during the pandemic.
The Brazil market dominated the LAMEA Biopsy Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $53.1 million by 2028.The Argentina market is experiencing a CAGR of 13.3% during (2022-2028). Additionally, The UAE market would display a CAGR of 12.4% during (2022-2028).
Based on Product, the market is segmented into Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps and Others. Based on Needle-based Biopsy Guns Type, the market is segmented into Vacuum-assisted Biopsy (VAB) Devices, Fine Needle Aspiration Biopsy (FNAB) Devices and Core Needle Biopsy (CNB) Devices. Based on Biopsy Guidance Systems Type, the market is segmented into Manual and Robotic. Based on Biopsy Needles Type, the market is segmented into Disposable and Reusable. Based on End-user, the market is segmented into Hospitals, Diagnostic & Imaging Center and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Hologic, Inc., Fujifilm Holdings Corporation, B. Braun Melsungen AG, Danaher Corporation, ConMed Corporation, Becton, Dickinson and Company, Cardinal Health, Inc., Argon Medical Devices, Inc., and Cook Medical, Inc.
Scope of the Study
By Product
- Needle-based Biopsy Guns
- Vacuum-assisted Biopsy (VAB) Devices
- Fine Needle Aspiration Biopsy (FNAB) Devices
- Core Needle Biopsy (CNB) Devices
- Biopsy Guidance Systems
- Manual
- Robotic
- Biopsy Needles
- Disposable
- Reusable
- Biopsy Forceps
- Others
By End-user
- Hospitals
- Diagnostic & Imaging Center
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Hologic, Inc.
- Fujifilm Holdings Corporation
- B.Braun Melsungen AG
- Danaher Corporation
- ConMed Corporation
- Becton, Dickinson and Company
- Cardinal Health, Inc.
- Argon Medical Devices, Inc.
- Cook Medical, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Biopsy Devices Market, by Product
1.4.2 LAMEA Biopsy Devices Market, by End User
1.4.3 LAMEA Biopsy Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition &Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Biopsy Devices Market by Product
3.1 LAMEA Needle-based Biopsy Guns Market by Country
3.2 LAMEA Biopsy Devices Market by Needle-based Biopsy Guns Type
3.2.1 LAMEA Vacuum-assisted Biopsy (VAB) Devices Market by Country
3.2.2 LAMEA Fine Needle Aspiration Biopsy (FNAB) Devices Market by Country
3.2.3 LAMEA Core Needle Biopsy (CNB) Devices Market by Country
3.3 LAMEA Biopsy Guidance Systems Market by Country
3.4 LAMEA Biopsy Devices Market by Biopsy Guidance Systems Type
3.4.1 LAMEA Manual Market by Country
3.4.2 LAMEA Robotic Market by Country
3.5 LAMEA Biopsy Needles Market by Country
3.6 LAMEA Biopsy Devices Market by Biopsy Needles Type
3.6.1 LAMEA Disposable Market by Country
3.6.2 LAMEA Reusable Market by Country
3.7 LAMEA Biopsy Forceps Market by Country
3.8 LAMEA Others Market by Country
Chapter 4. LAMEA Biopsy Devices Market by End User
4.1 LAMEA Hospitals Market by Country
4.2 LAMEA Diagnostic & Imaging Center Market by Country
4.3 LAMEA Others Market by Country
Chapter 5. LAMEA Biopsy Devices Market by Country
5.1 Brazil Biopsy Devices Market
5.1.1 Brazil Biopsy Devices Market by Product
5.1.1.1 Brazil Biopsy Devices Market by Needle-based Biopsy Guns Type
5.1.1.2 Brazil Biopsy Devices Market by Biopsy Guidance Systems Type
5.1.1.3 Brazil Biopsy Devices Market by Biopsy Needles Type
5.1.2 Brazil Biopsy Devices Market by End User
5.2 Argentina Biopsy Devices Market
5.2.1 Argentina Biopsy Devices Market by Product
5.2.1.1 Argentina Biopsy Devices Market by Needle-based Biopsy Guns Type
5.2.1.2 Argentina Biopsy Devices Market by Biopsy Guidance Systems Type
5.2.1.3 Argentina Biopsy Devices Market by Biopsy Needles Type
5.2.2 Argentina Biopsy Devices Market by End User
5.3 UAE Biopsy Devices Market
5.3.1 UAE Biopsy Devices Market by Product
5.3.1.1 UAE Biopsy Devices Market by Needle-based Biopsy Guns Type
5.3.1.2 UAE Biopsy Devices Market by Biopsy Guidance Systems Type
5.3.1.3 UAE Biopsy Devices Market by Biopsy Needles Type
5.3.2 UAE Biopsy Devices Market by End User
5.4 Saudi Arabia Biopsy Devices Market
5.4.1 Saudi Arabia Biopsy Devices Market by Product
5.4.1.1 Saudi Arabia Biopsy Devices Market by Needle-based Biopsy Guns Type
5.4.1.2 Saudi Arabia Biopsy Devices Market by Biopsy Guidance Systems Type
5.4.1.3 Saudi Arabia Biopsy Devices Market by Biopsy Needles Type
5.4.2 Saudi Arabia Biopsy Devices Market by End User
5.5 South Africa Biopsy Devices Market
5.5.1 South Africa Biopsy Devices Market by Product
5.5.1.1 South Africa Biopsy Devices Market by Needle-based Biopsy Guns Type
5.5.1.2 South Africa Biopsy Devices Market by Biopsy Guidance Systems Type
5.5.1.3 South Africa Biopsy Devices Market by Biopsy Needles Type
5.5.2 South Africa Biopsy Devices Market by End User
5.6 Nigeria Biopsy Devices Market
5.6.1 Nigeria Biopsy Devices Market by Product
5.6.1.1 Nigeria Biopsy Devices Market by Needle-based Biopsy Guns Type
5.6.1.2 Nigeria Biopsy Devices Market by Biopsy Guidance Systems Type
5.6.1.3 Nigeria Biopsy Devices Market by Biopsy Needles Type
5.6.2 Nigeria Biopsy Devices Market by End User
5.7 Rest of LAMEA Biopsy Devices Market
5.7.1 Rest of LAMEA Biopsy Devices Market by Product
5.7.1.1 Rest of LAMEA Biopsy Devices Market by Needle-based Biopsy Guns Type
5.7.1.2 Rest of LAMEA Biopsy Devices Market by Biopsy Guidance Systems Type
5.7.1.3 Rest of LAMEA Biopsy Devices Market by Biopsy Needles Type
5.7.2 Rest of LAMEA Biopsy Devices Market by End User
Chapter 6. Company Profiles
6.1 Medtronic PLC
6.1.1 Company overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 SWOT Analysis
6.2 Hologic, Inc
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Fujifilm Holdings Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expenses
6.4 B. Braun Melsungen AG
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.5 Danaher Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 ConMed Corporation
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.7 Becton, Dickinson and Company
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 Cardinal Health, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.9 Argon Medical Devices, Inc.
6.9.1 Company Overview
6.10. Cook Medical, Inc. (Cook Group)
6.10.1 Company Overview
Companies Mentioned
- Medtronic PLC
- Hologic, Inc.
- Fujifilm Holdings Corporation
- B. Braun Melsungen AG
- Danaher Corporation
- ConMed Corporation
- Becton, Dickinson and Company
- Cardinal Health, Inc.
- Argon Medical Devices, Inc.
- Cook Medical, Inc.
Methodology
LOADING...
